Abstract
A rapid, sensitive, and selective LC–UV–MS–MS method for simultaneous quantification of uric acid, creatinine, xanthine, creatine, hypoxanthine, adenosine, inosine, thymidine, and uridine in serum from patients with impaired glucose tolerance (IGT) has been developed and validated. After precipitation of protein in the serum with methanol samples were evaporated with a stream of nitrogen then reconstituted with aqueous ammonia (0.002 mol L−1). Chromatographic separation was performed on a C18 column with methanol–buffer (8 mmol L−1 ammonium acetate adjusted to pH 6.1 with glacial acetic acid) as mobile phase at a flow rate of 0.8 mL min−1. UV and MS–MS detection were used to quantify the metabolites on the basis of different concentrations and detector response. Linearity was excellent, with r 2 no <0.998. Recovery, and intra-day and inter-day relative standard deviation (RSD) were >85, <10, and <10%, respectively. This reliable bioanalytical method enables evaluation of the levels of purines and pyrimidines in serum for IGT studies and diagnosis.
References
Unwin N, Shaw J, Zimmet P, Alberti KGMM (2002) Diabet Med 19:708–723. doi:10.1046/j.1464-5491.2002.00835.x
Yang WY, Lu JM, Weng JP, Jia WP, Ji LN, Xiao JZ, Shan ZY, Liu J, Tian HM, Ji QH, Zhu DL, Ge JP, Lin LX, Chen L, Guo XH, Zhao ZG, Li Q, Zhou ZG, Shan GL, He J (2010) New Engl J Med 362:1090–1101
Niskanen L, Laaksonen DE, Lindstrom J, Eriksson JG, Keinanen-Kiukaanniemi S, Ilanne-Parikka P, Aunola S, Hamalainen H, Tuomilehto J, Uusitupa M (2006) Diabetes Care 29:709–711
Xia JF, Liang QL, Hu P, Wang YM, Li P, Luo GA (2009) Clin Biochem 42:215–220. doi:10.1016/j.clinbiochem.2008.10.009
Xia JF, Hu P, Liang QL, Zou TT, Wang YM, Luo GA (2010) Clin Biochem 43:957–962. doi:10.1016/j.clinbiochem.2010.05.013
Safranow K, Machoy Z (2005) J Chromatogr B 819:229–235. doi:10.1016/j.jchromb.2004.11.013
Zheng YF, Xu GW, Yang J, Zhao XJ, Pang T, Kong HW (2005) J Chromatogr B 819:85–90. doi:10.1016/j.jchromb.2005.01.033
Bennett MJ, Carpenter KH (1984) Ann Clin Biochem 21:131–136
MacNeil L, Hill L, MacDonald D, Keefe L, Cormier JF, Burke DG, Smith-Palmer T (2005) J Chromatogr B 827:210–215. doi:10.1016/j.jchromb.2005.09.011
Zhao JY, Liang QL, Luo G, Wang YM, Zuo YJ, Jiang M, Yu GL, Zhang T (2005) Clin Chem 51:1742–1744. doi:10.1373/clinchem.2004.040261
Kong Y, Zheng N, Zhang ZC, Gao RY (2003) J Chromatogr A 987:477–483. doi:10.1016/S0021-9673(02)01951-9
Xia JF, Liang QL, Liang XP, Wang YM, Hu P, Li P, Luo GA (2009) J Chromatogr B 877:1930–1936. doi:10.1016/j.jchromb.2009.05.047
Coulier L, Bas R, Jespersen S, Verheij E, van der Werf MJ, Hankemeier T (2006) Anal Chem 78:6573–6582. doi:10.1021/ac0607616
Jen JF, Hsiao SL, Liu KH (2002) Talanta 58:711–717. doi:10.1016/S0039-9140(02)00377-6
Arias A, Garcia-Villoria J, Ribes A (2004) Mol Genet Metab 82:220–223. doi:10.1016/j.ymgme.2004.04.009
la Marca G, Casetta B, Malvagia S, Pasquini E, Innocenti M, Donati MA, Zammarchi E (2006) J Mass Spectrom 41:1442–1452. doi:10.1002/jms.1115
Alberti KGMM, Zimmet PZ (1998) Diabet Med 15:539–553. doi:10.1002/(SICI)1096-9136(199807)15:7<539:AID-DIA668>3.0.CO;2-S
US Department of Health and Human Services (2001) Bioanalytical method validation guidance for industry. US Department of Health and Human Services, Food and Drug Administration, Center for Drug Evaluation and Research and Center for veterinary Medicines. http://www.fda.govt./cder/guidance/4252fnl.htm
International Conference on Harmonization (1996) Harmonised tripartite guideline, text on validation of analytical procedures, Q2B. In: International conference on harmonization of technical requirements for registration of pharmaceuticals for human use
Bo S, Cavallo-Perin P, Gentile L, Repetti E, Pagano G (2001) Eur J Clin Invest 31:318–321
Facchini F, Chen YDI, Hollenbeck CB, Reaven GM (1991) JAMA 266:3008–3011
Abdul-Ghani MA, Matsuda M, Sabbah M, Jenkinson C, Richardson D, Kaku K, DeFronzo RA (2007) Diabetes Metab Syndr Clin Res Rev 1:105–112. doi:10.1016/j.dsx.2007.02.004
Acknowledgments
These studies were supported by grants from the National Basic Research Development Program of China (no. 2005CB523503), the National Eleventh Five-Year Technology Support Program (no. 2006BAI04A04-02), and Heilongjiang Baoquan Pharmaceutical Co. Ltd.
Author information
Authors and Affiliations
Corresponding authors
Additional information
H. Zhong and Q. Liang contributed equally to this work.
Rights and permissions
About this article
Cite this article
Zhong, H., Liang, Q., Xia, J. et al. Simultaneous LC–UV–MS–MS Analysis of Nine Pivotal Metabolites in Human Serum: Application to Studies of Impaired Glucose Tolerance. Chromatographia 73, 149–155 (2011). https://doi.org/10.1007/s10337-010-1833-1
Received:
Revised:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s10337-010-1833-1